Hong Kong patients living with chronic conditions, persistent inflammation, or tissue damage that has plateaued with conventional treatment are exploring mesenchymal stem cell therapy as a regenerative option. Advanced MSC protocols are not widely accessible within Hong Kong's private healthcare network due to regulatory constraints. Our Chiang Mai clinic, under three hours from HKIA, delivers quality-controlled stem cell therapy with Cantonese-speaking support and coordination with your Hong Kong medical team.
Mesenchymal stem cell (MSC) therapy uses laboratory-expanded stem cells to target tissue damage, reduce chronic inflammation, and promote cellular repair. Cells are quality-tested and delivered under imaging guidance to ensure precise targeting of affected areas. The treatment process involves initial assessment, cell preparation by our laboratory team, and image-guided delivery to the treatment site. For a comprehensive understanding of the science, evidence, and treatment process, visit our full Stem Cell Therapy page.
Hong Kong patients value the quality-controlled MSC protocols, the structured clinical governance, and the significant cost difference compared to the limited domestic options available. Each stem cell programme is individually designed based on diagnostic assessment and treatment goals rather than a one-size-fits-all approach. Cantonese-speaking clinical staff ensure that patients fully understand the treatment process, expected outcomes, and follow-up requirements. Comprehensive treatment records are provided for your Hong Kong specialist or physiotherapist to support ongoing care.
Advanced stem cell protocols are limited in Hong Kong. Thailand offers broader access under medical supervision.
Five to seven days in Chiang Mai.
Yes.
Yes. Many Hong Kong patients combine stem cell therapy with anti-ageing protocols.
Structured remote consultations at scheduled intervals.
Yes. Comprehensive treatment summaries are provided.
The MCHK restricts the advertising and promotion of treatments it considers unproven or experimental. There is no dedicated regulatory pathway for commercial stem cell treatments under the Department of Health, and the Pharmacy and Poisons Ordinance restricts the importation of certain biological products, severely limiting the number of private providers.
Public hospitals under the Hospital Authority do not offer regenerative stem cell protocols. Private clinics that do offer any form of stem cell treatment charge extremely high fees reflecting Hong Kong's premium operating costs, with limited protocol options compared to specialist centres in Thailand.
Yes. Our Cantonese-speaking coordinators handle all communication from initial enquiry through treatment. Clinical documentation and follow-up consultations are available in Cantonese or English.